Disc Medicine (IRON) Total Current Liabilities (2020 - 2026)
Disc Medicine's (IRON) quarterly Total Current Liabilities came in at $31.1 million in Q1 2026, up 66.17% year-on-year from $18.7 million in Q1 2025, and down 15.01% on a QoQ basis from $36.6 million in Q4 2025.
Disc Medicine (IRON) Total Current Liabilities (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Total Current Liabilities data on file, last reported at $31.1 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 66.17% year-over-year to $31.1 million in Q1 2026; TTM through Mar 2026 was $31.1 million, a 66.17% increase from a year earlier, with the FY2025 full-year figure at $36.6 million, up 57.15% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $31.1 million, down from $36.6 million in the prior quarter.
- Over the last five years, Total Current Liabilities for IRON reached as high as $36.6 million in Q4 2025 and fell as low as $1.5 million in Q3 2022.
- Historically, Total Current Liabilities has averaged $18.6 million across 5 years, with a median of $20.3 million in 2024.
- Across the five-year window, Total Current Liabilities sank 88.44% in 2022 and surged 884.7% in 2023, its largest moves.
- Year by year, Total Current Liabilities stood at $22.6 million in 2022, then slipped by 5.04% to $21.4 million in 2023, then rose by 8.76% to $23.3 million in 2024, then surged by 57.15% to $36.6 million in 2025, then dropped by 15.01% to $31.1 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $31.1 million in Q1 2026, $36.6 million in Q4 2025, and $26.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - | 31.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.14 Mn |
| Dec 31, 2025 | 36.64 Mn |
| Sep 30, 2025 | 26.74 Mn |
| Jun 30, 2025 | 20.61 Mn |
| Mar 31, 2025 | 18.74 Mn |
| Dec 31, 2024 | 23.32 Mn |
| Sep 30, 2024 | 25.47 Mn |
| Jun 30, 2024 | 20.31 Mn |
| Mar 31, 2024 | 14.85 Mn |
| Dec 31, 2023 | 21.44 Mn |
| Sep 30, 2023 | 14.42 Mn |
| Jun 30, 2023 | 9.68 Mn |
| Mar 31, 2023 | 9.98 Mn |
| Dec 31, 2022 | 22.58 Mn |
| Sep 30, 2022 | 1.46 Mn |
| Jun 30, 2022 | 6.44 Mn |
| Mar 31, 2022 | 12.67 Mn |
| Dec 31, 2021 | 13.42 Mn |
| Sep 30, 2021 | 12.66 Mn |
| Jun 30, 2021 | 11.51 Mn |